Skip to main content

CITIGROUP INC

Position in REPL — Replimune Group, Inc.

CIK 831001 NEW YORK, NY

Position in REPL

as of Jun 30, 2026 · filed Aug 3, 2026
Position Value
$1,205,268
+$1,086,013 QoQ
Shares Held
108,877
+598.4% QoQ
Ownership
0.116%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#57
of 199 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in REPL Over Time

Shares Held

Position Value (USD)

Derivatives in REPL

reported options exposure · as of Jun 30, 2026
CallValue
$0
CallShares
0
PutValue
$3,321,000
PutShares
300,000

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

CITIGROUP INC holds $2,085,225,397 across 384 Biotechnology names. REPL ranks #137 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in REPL

Export CSV
27 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $3,321,000 300,000
2026-06-30 $1,205,268 108,877
2026-03-31 $119,255 15,589
2025-12-31 $196,285 20,194
2025-09-30 $29,861 7,127
2025-06-30 $366,350 39,435
2025-03-31 $1,125,822 115,469
2024-12-31 $1,033,938 85,379
2024-09-30 $501,112 45,722
2024-06-30 $178,767 19,863
2024-03-31 $4,432,134 542,489
2023-12-31 $1,544,890 183,261
2023-09-30 $1,360,706 79,527
2023-06-30 $1,241,526 53,468
2023-03-31 $3,072,416 173,976
2022-12-31 $929,668 34,179
2022-09-30 $1,209,487 70,034
2022-06-30 $1,050,670 60,107
2022-03-31 $306,624 18,058
2021-12-31 $1,632,504 60,240
2021-09-30 $1,355,970 45,748
2021-06-30 $4,112,707 107,046
2021-03-31 $3,711,297 121,642
2020-12-31 $246,372 6,458
2020-09-30 $27,969 1,215
2020-06-30 $108,619 4,371
2020-03-31 $254,972 25,574